Page 21 - S&p Bse Sensex

Stock Market Highlights: D-St ends 2-day losing streak; Nifty ends at 25,763; Realty, PSU banks lead

Sensex today | Stock market highlights on November 3: Nifty Midcap 100 index closed 0.77 per cent higher, while Nifty SmallCap 100 index settled 0.72 per cent higher

BPCL shares rise 2% after positive earnings; Q2 breakdown here

BPCL shares rose after it reported a 168 per cent Y-o-Y jump in standalone net profit at ₹6,442 crore for the second quarter

Titagarh Rail shares rise 4% on ₹2,481-crore MMRDA order win; details here

Titagarh Rail bagged a ₹2,481-crore order from the Mumbai Metropolitan Region Development Authority (MMRDA) for Mumbai Metro Line 5

Patanjali Foods shares slide 5% even after positive Q2 show; details here

Patanjali Foods reported a 67 per cent increase in its consolidated net profit to ₹516.69 crore for the second quarter of this financial year

Urban Company shares slip 7% as Q2 loss widens; check details

Urban Company reported a 37 per cent year-on-year growth in revenue from operations, while its losses widened to ₹59.3 crore

Godrej Consumer shares climb 6% on upbeat outlook post Q2 results

Godrej Consumer Products' shares rallied even after its net profit fell 6.5 per cent in the July-September quarter to ₹459.3 crore

Suraj Estate Developers spikes 14% on posting Q2 results; details here

In Q2, Suraj Estate Developers reported a consolidated net profit of ₹33.1 crore, as compared to ₹31.8 crore a year ago, up 4 per cent

Nifty IT set for best month since July 2024; but is it out of the woods?

Analysts remain mixed on IT stocks' outlook, with some cautioning that the optimism around the technology pack could be short-lived

Tata Chemicals shares rise on winning ₹783-crore land rate dispute in Kenya

Tata Chemicals shares rose 2 per cent after a Nairobi court ruled in favour of its unit, terming the ₹783 crore land rate demand arbitrary and illegal

Can Vi stock see more upside after SC's AGR ruling? Analysts weigh in

Motilal Oswal Financial Services upgraded the stock to a 'Neutral' rating, and upped the target price to ₹10 per share, from ₹6.5 apiece earlier

Vi shares hit 52-week high; up 9% as SC allows Govt to reconsider AGR dues

Vodafone Idea shares rose 9 per cent after Supreme Court allowed the government to reconsider the adjusted gross revenue issue

Reliance Industries shares rise 2% after incorporating JV with Meta for AI

RIL shares were among the top gainers, rising over 2 per cent, after it incorporated REIL, a joint venture with Meta

ITC Hotels stock upgraded to 'Add' at JM Financial after Q2; check target

JM Financial revised the ITC Hotels' target price to ₹235 per share, from ₹215 apiece earlier, after it reported its Q2 earnings

Steady growth, firm margins lift SBI Life to 52-wk high; analysts keep Buy

At 10 AM, SBI Life share price continued to trade in the northward direction, up 3.37 per cent at ₹1,902.60 per share. By comparison, BSE Sensex was trading 0.57 per cent higher at 84,695.60 levels.

GPT Infra shares soar 13% on ₹195-crore order win; details here

GPT Infraprojects shares rose 13 per cent on ₹195-crore contract from Terminal Industriel Polyvalent de San Pedro, Ivory Coast

Brigade Hotel shares rally as Q2 profit jumps 58%; results breakdown here

Brigade Hotel shares rose 8 per cent after it reported a 57.97 per cent jump in its September quarter net profit

Vedanta shares advance 3% on ₹1-trillion Odisha investment plan

Vedanta shares rose 3 per cent after it said it will invest an ₹1 trillion in Odisha, helping create over 1 lakh employment opportunities

Antique sees 'tremendous' scope in ₹2.5-trn worth FY26 defence proposals

On Thursday, the MoD said the Defence Acquisition Council approved procurement proposals worth ₹79,000 crore

Stocks to Watch today: Colgate, HUL, Defence stocks, NTPC Green, Cipla, Vi

Stocks to Watch today: Colgate, Hindustan Unilever, Defence stocks, Vedanta, Kaynes Technology, NTPC Greent, and Indian Hotels are among the stocks to watch today, October 24, 2025

Nuvama retains 'Hold' on Cipla, raises target after Eli Lilly diabetes deal

Cipla- Eli Lilly deal: Tirzepatide is a prescription drug used for managing type 2 diabetes and aiding weight loss in adults who are obese or overweight.